w80tw8i

Property	Value
?:abstract	Coronavirus disease 2019 (COVID‐19) pandemic is affecting a high percentage of the population at an unprecedented rate. Cancer patients comprise a subgroup especially vulnerable to this infection. Herein, we present a prospective analysis of epidemiological, clinical, radiological and laboratory data of consecutive adult cancer patients seen in the Clínico San Carlos University Hospital (Madrid, Spain), and admitted to hospital and tested for COVID‐19 between 21 February 2020 and 8 May 2020 due to clinical suspicion of infection. Data from 73 patients with confirmed COVID‐19 and active solid tumors or diagnosed within the previous 5 years were analyzed. The most frequent malignancy was lung cancer (19%) and 54 patients (74%) were on active cancer treatment. Most common findings on presentation included cough (55%), fever (52%) and dyspnea (45%), and 32 (44%) patients showed oxygen saturation levels below 95%. Radiologically, 54 (73%) patients presented an abnormal pattern, the most frequent being infiltrates (64%). 18 (24.7%) patients died in hospital and 55 (75.3%) were discharged with clinical resolution of the event. Multivariable logistic regression adjusted for age and tumor stage showed higher odds of in‐hospital death associated with a history of cardiovascular disease, hospitalization in the previous 30 days, and several features on admission including dyspnea, higher qSOFA score, higher C‐reactive protein levels and an abnormal neutrophil count. We present prospective, real‐world evidence that can help articulate cancer care protocols for patients infected with SARS‐CoV‐2, with special focus on features on admission that can stratify patients with a higher risk of death from COVID‐19.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C0006826> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C0010200> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C0013404> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C0015967> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C0242379> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C0280100> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C0332448> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C1415068> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C1826357> <https://research.tib.eu/covid-19/entity/6w80tw8i_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Fuentes%E2%80%90Antr%C3%A1s%2C_Jes%C3%BAs%3B_Manzano%2C_Ar%C3%A1nzazu%3B_Marquina%2C_Gloria%3B_Paz%2C_Mateo%3B_Aguado%2C_Carlos%3B_Granja%2C_M%C3%B3nica%3B_Ben%C3%ADtez%2C_Javier%3B_Ortega%2C_Justo%3B_Priego%2C_Araceli%3B_Gonz%C3%A1lez%2C_Carlos%3B_Tejerina%E2%80%90Peces%2C_Julia%3B_Flores%2C_Paloma%3B_de_Sa%2C_Alfonso_L%C3%B3pez%3B_Toledano%2C_Carmen%3B_Olalla%2C_Jennifer%3B_de_Luna%2C_Alicia%3B_Bartolom%C3%A9%2C_Jorge%3B_P%C3%A9rez%E2%80%90Segura%2C_Pedro>
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/ijc.33420>
?:doi	10.1002/ijc.33420
?:journal	Int_J_Cancer
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/b70c0d7cb84a80a6e78503fdb1964cb89a256ff7.json
?:pmc_json_files	document_parses/pmc_json/PMC7753395.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7753395>
?:pmid	<https://research.tib.eu/covid-19/entity/33270902.0>
?:pmid	33270902.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/b70c0d7cb84a80a6e78503fdb1964cb89a256ff7>
?:source	Medline; PMC
?:title	A snapshot of COVID‐19 infection in patients with solid tumors
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-19

Property

Value

?:abstract

Coronavirus disease 2019 (COVID‐19) pandemic is affecting a high percentage of the population at an unprecedented rate. Cancer patients comprise a subgroup especially vulnerable to this infection. Herein, we present a prospective analysis of epidemiological, clinical, radiological and laboratory data of consecutive adult cancer patients seen in the Clínico San Carlos University Hospital (Madrid, Spain), and admitted to hospital and tested for COVID‐19 between 21 February 2020 and 8 May 2020 due to clinical suspicion of infection. Data from 73 patients with confirmed COVID‐19 and active solid tumors or diagnosed within the previous 5 years were analyzed. The most frequent malignancy was lung cancer (19%) and 54 patients (74%) were on active cancer treatment. Most common findings on presentation included cough (55%), fever (52%) and dyspnea (45%), and 32 (44%) patients showed oxygen saturation levels below 95%. Radiologically, 54 (73%) patients presented an abnormal pattern, the most frequent being infiltrates (64%). 18 (24.7%) patients died in hospital and 55 (75.3%) were discharged with clinical resolution of the event. Multivariable logistic regression adjusted for age and tumor stage showed higher odds of in‐hospital death associated with a history of cardiovascular disease, hospitalization in the previous 30 days, and several features on admission including dyspnea, higher qSOFA score, higher C‐reactive protein levels and an abnormal neutrophil count. We present prospective, real‐world evidence that can help articulate cancer care protocols for patients infected with SARS‐CoV‐2, with special focus on features on admission that can stratify patients with a higher risk of death from COVID‐19.

is ?:annotates of